Cost-Effectiveness Analysis of Treatment of Venous Thromboembolism With Rivaroxaban Compared With Combined Low Molecular Weight Heparin/Vitamin K Antagonist
Thrombosis Journal - United Kingdom
doi 10.1186/s12959-015-0051-3
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 11, 2015
Authors
Publisher
Springer Science and Business Media LLC